| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.08 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |